Oxford Global is proud to announce that early bird registration is open for the 4th Annual Stem Cell Congress, 6-7 November 2017 in London. Across the two days 250+ senior level attendees will join us in London to hear 20+ presentations and case studies giving you the chance to explore the key areas shaping this exclusive field of genomic medicine.

 

Stem Cell Bioprocessing

Industry Spotlight Presentations

Stem Cell Therapy Development: Clinical Trials

 

Precise genome modification techniques in Knockout and Knockin mutations Ryan Hicks, Associate Director Stem & Primary Cell Group, AstraZeneca

3D biomaterial culture systems for stem cell expansion and differentiation David Schaffer, Director, Berkeley Stem Cell Center

Development of novel stem cell therapeutics for stroke disability John Sinden, Chief Scientific Officer, ReNueron

Non-iPSC approach for diabetes Nagy Habib, Professor, Imperial College London

 

This congress also gives access to our co-located 3rd Annual Cell & Gene Therapy Congress and 6th Annual Cell Culture & Bioprocessing Congress and offers a shared networking environment for attendees to gain valuable insights into this advancing industry.